Investigate the role of glutathione S Transferase (GST) polymorphism in development of hypertension in UAE population

Iranian Red Crescent Medical Journal

Volumn 14, Issue 8, 2012, Pages 5-

  Hussain, Kosar ^a   Salah, Neveen ^b   Hussain, Sahar ^c   Hussain, Sara ^b  

^a DUBAI HEALTH AUTHORITY   (United Arab Emirates)

^b DUBAI MEDICAL COLLEGE   (United Arab Emirates)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Genetic; Glutathione S trailslase Tl; Hypertension; Polymorphism

Indexed keywords

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; GSTM 1 GENE; GSTT 1 GENE; HUMAN; HYPERTENSION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; RISK FACTOR; UNITED ARAB EMIRATES;

EID: 84864630955     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weseler AR, Bast A. Oxidative stress and vascular function: implications for pharmacologic treatments. Curr Hypertens Rep. 2010;12(3):154-61.
2. Montezano AC, Touyz RM. Oxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies. Ann Med. 2012;44 Suppl 1:S2-S16.
3. Schulz E, Gori T, Munzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34(6):665-73.
4. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008;10(6):1115-26.
5. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61(3):154-66.
6. He NG, Awasthi S, Singhal SS, Trent MB, Boor PJ. The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall. Toxicol Appl Pharmacol. 1998;152(1):83-9.
7. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894: i-xii, 1-253.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
9. Rifal N, bachnorik PS, Albers JJ. Lipids, lipoproteins and apolipoproteins. In: Burtis CA, Ashwood ER, editors. Tietz Text book of clinical chemistry. 3RD ed. Philadelphi: W.B Saunders Company; 1999. p. 809-61.
10. Josef S, David WR, Nina I, Kaaren AJ. MOLECULAR CLONING: Rapid Isolation Of Mammalian DNA. New York: Cold Spring Harbour Laboratory Press; 2002.
11. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev. 1998;22(2):129-38.
12. Joseph S, David WR. Gel Electrophoresis of DNA. Cold Sprimg Harbor Laboratory. 3rd ed.: Press New York; 2001.
13. Mittal RD, Srivastava DS, Mandhani A, Kumar A, Mittal B. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: a study from North India. Indian J Cancer. 2004;41(3):115-9.
14. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002;23(8):360-6.
15. Schiffrin EL. Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens. 2002;15(10 Pt 2):115S-22S.
16. Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension. 2001;38(3 Pt 2):606-11.
17. Tang JJ, Wang MW, Jia EZ, Yan JJ, Wang QM, Zhu J, et al. The common variant in the GSTM1 and GSTT1 genes is related to markers of oxidative stress and inflammation in patients with coronary artery disease: a case-only study. Mol Biol Rep. 2010;37(1):405-10.
18. Rybka J, Kupczyk D, Kedziora-Kornatowska K, Motyl J, Czuczejko J, Szewczyk-Golec K, et al. Glutathionerelated antioxidant defense system in elderly patients treated for hypertension. Cardiovasc Toxicol. 2011;11(1):1-9.
19. Marinho C, Alho I, Arduino D, Falcao LM, Bras-Nogueira J, Bicho M. GST M1/T1 and MTHFR polymorphisms as risk factors for hypertension. Biochem Biophys Res Commun. 2007;353(2):344-50.
20. Polimanti R, Piacentini S, Lazzarin N, Re MA, Manfellotto D, Fuciarelli M. Glutathione S-transferase variants as risk factor for essential hypertension in Italian patients. Mol Cell Biochem. 2011;357(1- 2):227-33.
21. Capoluongo E, Onder G, Concolino P, Russo A, Santonocito C, Bernabei R, et al. GSTM1-null polymorphism as possible risk marker for hypertension: results from the aging and longevity study in the Sirente Geographic Area (ilSIRENTE study). Clin Chim Acta. 2009;399(1-2):92-6.
22. Oniki K, Hori M, Takata K, Yokoyama T, Mihara S, Marubayashi T, et al. Association between glutathione Stransferase A1, M1 and T1 polymorphisms and hypertension. Pharmacogenet Genomics. 2008;18(3):275-7.
23. Kurukulasuriya LR, Stas S, Lastra G, Manrique C, Sowers JR. Hypertension in obesity. Med Clin North Am. 2011;95(5):903-17.
24. Rocchini AP. Obesity hypertension. Am J Hypertens. 2002;15(2 Pt 2):50S-2S.
25. Mulrow CD, Chiquette E, Angel L, Grimm R, Cornell J, Summerbell CD, et al. WITHDRAWN: Dieting to reduce body weight for controlling hypertension in adults. Cochrane Database Syst Rev. 2008(4):CD000484.